MARKETABILITY / WAIVER (use this wording, if necessary) Your participation in this portion of the research study could lead to the development of commercial or other products that could eventually be protected by patents or other intellectual property rights. However, you will not be able to gain any financial benefit from this. COMPENSATION (adapt as necessary) You will not receive any compensation for your participation in this portion of the research study. AND INDEMNIFICATION IN CASE OF PREJUDICE PARTICIPANT’S RIGHTS By accepting to take part in this portion of the research study, you do not waive any of your legal rights nor do you release the investigators, the sponsor or the institution where this research study is being conducted from their civil and professional responsibilities. FUNDING OF THE RESEARCH STUDY The investigator in charge of the study and the institution received funding from the sponsor to carry out this study. The amounts received cover all study expenses. CONTACT PERSONS (adapt if necessary) If you have questions about your participation in this research study, please contact Dr. name of the principal investigator, principal investigator or his/her research nurse at phone number or by pager pager number. For any question about your rights as a participant in this study or if you have comments or wish to file a complaint, you can contact the local Commissioner for Complaints and Quality Services of the CISSS de la Montérégie-Centre at the following number 450 4665434. MONITORING OF ETHICAL ASPECTS OF THE STUDY The Research Ethics Board approved this study and is in charge of its monitoring. Furthermore, we guarantee that any modification to the study protocol or to this information and consent form will be submitted to the REB’s approval. If you want to contact the REB, please reach the secretariat at the following number: 450 4665000, ext. 2564.
MARKETABILITY / WAIVER (use this wording, if necessary) Your participation in this portion of the research study could lead to the development of commercial or other products that could eventually be protected by patents or other intellectual property rights. However, you will not be able to gain any financial benefit from this. COMPENSATION (adapt as necessary) You will not receive any compensation for your participation in this portion of the research study. PARTICIPANT’S RIGHTS AND INDEMNIFICATION IN CASE OF PREJUDICE By accepting to take part in this portion of the research study, you do not waive any of your legal rights nor do you release the investigators, the sponsor or the institution where this research study is being conducted from their civil and professional responsibilities. FUNDING OF THE RESEARCH STUDY The investigator in charge of the study and the institution received funding from the sponsor to carry out this study. The amounts received cover all study expenses. CONTACT PERSONS (adapt if necessary) If you have questions about your participation in this research study, please contact Dr. name of the principal investigator, principal investigator or his/her research nurse at phone number or by pager pager number. For any question about your rights as a participant in this study or if you have comments or wish to file a complaint, you can contact the local Commissioner for Complaints and Quality Services of the CISSS de la Montérégie-Centre at the following number 450 4665434. MONITORING OF ETHICAL ASPECTS OF THE STUDY The Research Ethics Board approved this study and is in charge of its monitoring. Furthermore, we guarantee that any modification to the study protocol or to this information and consent form will be submitted to the REB’s approval. If you want to contact the REB, please reach the secretariat at the following number: 450 4665000, ext. 2564.
FCE_Mise-en-banque_ANG_v1-du-CISSSMC-du-2017-05-09.docx